Radiopharmaceutical Supply – Tc-99m MDP

The contract involves the supply of Tc-99m Methylene Diphosphonate (MDP) for use in bone scintigraphy procedures, requiring end-to-end management including radiolabeling, quality control validation, and cold chain logistics to ensure product integrity. The vendor must deliver clinically compliant, sterile, pyrogen-free batches prepared in accordance with regulatory standards, with strict adherence to expiration timelines and temperature-controlled transportation protocols to designated healthcare facilities. All processes must be documented and traceable to support regulatory compliance and patient safety. This is a subcontract under the Department of Veterans Affairs, managed by the 255-NETWORK Contract Office 15, with solicitation posted on May 7, 2026, and responses due by May 15, 2026, at 12:00 PM. The NAICS code 325412 identifies the activity as pharmaceutical preparation manufacturing, indicating the supplier must qualify as a specialized radiopharmaceutical producer capable of handling short-lived isotopes and meeting stringent federal healthcare supply requirements. The place of performance and point of contact details are not specified, but delivery is anticipated to service VA medical centers nationwide under a controlled distribution model.